PerpEquities

Equity · Healthcare

Is McKesson Corporation (MCK) tradable as a perp? Not yet

McKesson Corporation is a global healthcare services provider operating in the US and internationally, with four segments covering pharmaceutical distribution, medical-surgical supplies, and prescription technology solutions.

Not yet listed on any perp exchange

No perpetual-futures venue lists MCK yet. We track it continuously; as soon as the first listing appears, this page becomes a full market page. Until then: fundamentals below and tradable alternatives.

Similar stocks already tradable as perps
REGNVRTXISRGBSXMRNAPFE

Price chart

Interactive TradingView chart

TradingView symbol NYSE:MCK

Loads TradingView's third-party widget (about 1 MB) on demand.

Auto: underlying reference priceOpen in TradingView

Company data

Company fundamentals

Updated 5h ago
Market cap
$102.4B
Updated 5h ago
Revenue
$411B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+1.1%
P/E
23.3
Peer P/E 24.0
Free cash flow
$6.2B
Trailing 12 months
More metrics
Net income
$4.6B
Trailing 12 months
P/S
0.2
Peer P/E
24.0
Similar listed perps
Revenue estimate
$431.9B
Next fiscal year
Earnings
2026-11-04
Revenue est. $109.9B · Updated 5h ago
Dividend
$0.94
2026-09-01

Fundamental detail

Annual + quarterly
Latest revenue$403.4B
Net margin+1.2%
Free cash flow$5.4B
Net debt$4.6B
2021$238.2B
2022$264B
2023$276.7B
2024$309B
2025$359.1B
2026$403.4B
PeriodRevenueGrowthNet incomeFCF
2021$238.2B+3%-$4.5B$3.9B
2022$264B+11%$1.1B$3.9B
2023$276.7B+5%$3.6B$4.6B
2024$309B+12%$3B$3.6B
2025$359.1B+16%$3.3B$5.2B
2026$403.4B+12%$4.8B$5.4B
PeriodGross marginOperating marginNet marginROEROA
2021+4.9%+1.5%-1.9%+21,614.3%-7.0%
2022+4.8%+1.0%+0.4%-49.0%+1.8%
2023+4.3%+1.6%+1.3%-191.7%+5.7%
2024+3.9%+1.3%+1.0%-152.3%+4.5%
2025+3.5%+1.2%+0.9%-158.9%+4.4%
2026+3.6%+1.6%+1.2%-219.2%+5.8%
PeriodCashDebtNet debtCurrent ratio
2021$6.3B$9.4B$3.1B1.03
2022$3.5B$7.5B$4B0.95
2023$4.7B$7.3B$2.6B0.92
2024$4.6B$7.4B$2.8B0.92
2025$5.7B$7.4B$1.7B0.90
2026$4B$8.6B$4.6B0.85
PeriodMarket capEnterprise valueP/SP/E
2021$31.3B$34.5B0.1-7.2
2022$46.6B$50.6B0.241.9
2023$50.2B$52.9B0.214.1
2024$71.5B$74.3B0.223.8
2025$85.7B$87.4B0.226.0
2026$107B$111.6B0.322.4
Q2 2025$93.7B
Q3 2025$95.3B
Q4 2025$90.8B
Q1 2026$97.8B
Q2 2026$103.2B
Q3 2026$106.2B
Q4 2026$96.3B
Q1 2027$105.4B
PeriodRevenueGrowthNet incomeFCF
Q2 2025$93.7B+21%$241M$1.9B
Q3 2025$95.3B+18%$879M-$2.6B
Q4 2025$90.8B+19%$1.3B$7.5B
Q1 2026$97.8B+23%$784M-$1.1B
Q2 2026$103.2B+10%$1.1B$2.2B
Q3 2026$106.2B+11%$1.2B$1.1B
Q4 2026$96.3B+6%$1.7B$3.2B
Q1 2027$105.4B+8%$614M-$332M
PeriodGross marginOperating marginNet marginROEROA
Q2 2025+3.4%+0.8%+0.3%-8.0%+0.3%
Q3 2025+3.4%+1.4%+0.9%-28.5%+1.2%
Q4 2025+3.2%+1.1%+1.4%-60.8%+1.7%
Q1 2026+3.4%+1.1%+0.8%-39.9%+1.0%
Q2 2026+3.4%+1.4%+1.1%-63.8%+1.3%
Q3 2026+3.5%+1.5%+1.1%-91.4%+1.4%
Q4 2026+4.2%+2.3%+1.7%-77.4%+2.0%
Q1 2027+3.5%+1.3%+0.6%-14.5%+0.7%
PeriodCashDebtNet debtCurrent ratio
Q2 2025$2.5B$7.2B$4.7B0.91
Q3 2025$1.1B$9.8B$8.6B0.88
Q4 2025$5.7B$7.4B$1.7B0.90
Q1 2026$2.4B$9.9B$7.5B0.88
Q2 2026$4.1B$9.8B$5.7B0.88
Q3 2026$3B$8.6B$5.7B0.88
Q4 2026$4B$8.6B$4.6B0.85
Q1 2027$5.2B$11.7B$6.5B0.89
PeriodMarket capEnterprise valueP/SP/E
Q2 2025$63.6B$68.3B0.766.1
Q3 2025$71.8B$80.4B0.820.4
Q4 2025$84.3B$86B0.916.7
Q1 2026$91.5B$99B0.929.2
Q2 2026$95.8B$101.5B0.921.6
Q3 2026$101.1B$106.7B1.021.3
Q4 2026$105.7B$110.3B1.115.7
Q1 2027$89.7B$96.2B0.936.5

Refreshed 5h ago

Charts: revenue, profit, cash flow & valuation
Revenue$105.4BQ1 2027
$26.5B$53.1B$79.6B$106.2BQ2 2024: $77.2BQ3 2024: $80.9BQ4 2024: $76.4BQ1 2025: $79.3BQ2 2025: $93.7BQ3 2025: $95.3BQ4 2025: $90.8BQ1 2026: $97.8BQ2 2026: $103.2BQ3 2026: $106.2BQ4 2026: $96.3BQ1 2027: $105.4BQ2 2024Q1 2027
Net income$614MQ1 2027
$420.5M$841M$1.3B$1.7BQ2 2024: $664MQ3 2024: $589MQ4 2024: $791MQ1 2025: $915MQ2 2025: $241MQ3 2025: $879MQ4 2025: $1.3BQ1 2026: $784MQ2 2026: $1.1BQ3 2026: $1.2BQ4 2026: $1.7BQ1 2027: $614MQ2 2024Q1 2027
EBITDA$1.4BQ1 2027
$565M$1.1B$1.7B$2.3BQ2 2024: $1.1BQ3 2024: $835MQ4 2024: $1.4BQ1 2025: $1.3BQ2 2025: $775MQ3 2025: $1.4BQ4 2025: $1.7BQ1 2026: $1.3BQ2 2026: $1.7BQ3 2026: $1.8BQ4 2026: $2.3BQ1 2027: $1.4BQ2 2024Q1 2027
Free cash flow-$332MQ1 2027
-$66.8M$2.4B$5B$7.5BQ2 2024: $825MQ3 2024: $100MQ4 2024: $3.9BQ1 2025: -$1.5BQ2 2025: $1.9BQ3 2025: -$2.6BQ4 2025: $7.5BQ1 2026: -$1.1BQ2 2026: $2.2BQ3 2026: $1.1BQ4 2026: $3.2BQ1 2027: -$332MQ2 2024Q1 2027
EPS$5.15Q1 2027
$3.43$6.86$10.3$13.7Q2 2024: $4.93Q3 2024: $4.42Q4 2024: $6.01Q1 2025: $7Q2 2025: $1.86Q3 2025: $6.94Q4 2025: $10Q1 2026: $6.25Q2 2026: $8.92Q3 2026: $9.59Q4 2026: $13.7Q1 2027: $5.15Q2 2024Q1 2027
Cash / Debt$5.2BQ1 2027
$2.9B$5.9B$8.8B$11.7BQ2 2024 · Cash: $2.5BQ2 2024 · Debt: $7.3BQ3 2024 · Cash: $2BQ3 2024 · Debt: $7.6BQ4 2024 · Cash: $4.6BQ4 2024 · Debt: $7.4BQ1 2025 · Cash: $2.3BQ1 2025 · Debt: $7.4BQ2 2025 · Cash: $2.5BQ2 2025 · Debt: $7.2BQ3 2025 · Cash: $1.1BQ3 2025 · Debt: $9.8BQ4 2025 · Cash: $5.7BQ4 2025 · Debt: $7.4BQ1 2026 · Cash: $2.4BQ1 2026 · Debt: $9.9BQ2 2026 · Cash: $4.1BQ2 2026 · Debt: $9.8BQ3 2026 · Cash: $3BQ3 2026 · Debt: $8.6BQ4 2026 · Cash: $4BQ4 2026 · Debt: $8.6BQ1 2027 · Cash: $5.2BQ1 2027 · Debt: $11.7BQ2 2024Q1 2027
CashDebt
Profitability+3.5%Q1 2027
+1.1%+2.3%+3.4%+4.5%Q2 2024 · Gross margin: +3.8%Q3 2024 · Gross margin: +3.7%Q4 2024 · Gross margin: +4.5%Q1 2025 · Gross margin: +3.7%Q2 2025 · Gross margin: +3.4%Q3 2025 · Gross margin: +3.4%Q4 2025 · Gross margin: +3.2%Q1 2026 · Gross margin: +3.4%Q2 2026 · Gross margin: +3.4%Q3 2026 · Gross margin: +3.5%Q4 2026 · Gross margin: +4.2%Q1 2027 · Gross margin: +3.5%Q2 2024 · Operating margin: +1.2%Q3 2024 · Operating margin: +0.8%Q4 2024 · Operating margin: +1.8%Q1 2025 · Operating margin: +1.3%Q2 2025 · Operating margin: +0.8%Q3 2025 · Operating margin: +1.4%Q4 2025 · Operating margin: +1.1%Q1 2026 · Operating margin: +1.1%Q2 2026 · Operating margin: +1.4%Q3 2026 · Operating margin: +1.5%Q4 2026 · Operating margin: +2.3%Q1 2027 · Operating margin: +1.3%Q2 2024 · Net margin: +0.9%Q3 2024 · Net margin: +0.7%Q4 2024 · Net margin: +1.0%Q1 2025 · Net margin: +1.2%Q2 2025 · Net margin: +0.3%Q3 2025 · Net margin: +0.9%Q4 2025 · Net margin: +1.4%Q1 2026 · Net margin: +0.8%Q2 2026 · Net margin: +1.1%Q3 2026 · Net margin: +1.1%Q4 2026 · Net margin: +1.7%Q1 2027 · Net margin: +0.6%Q2 2024Q1 2027
Gross marginOperating marginNet margin
Revenue growth+7.7%Q1 2027
+5.8%+11.7%+17.5%+23.4%Q2 2025: +21.3%Q3 2025: +17.8%Q4 2025: +18.9%Q1 2026: +23.4%Q2 2026: +10.1%Q3 2026: +11.4%Q4 2026: +6.0%Q1 2027: +7.7%Q2 2024Q1 2027
Shares outstanding119.2MQ1 2027
33.7M67.4M101.1M134.8MQ2 2024: 134.8MQ3 2024: 133.3MQ4 2024: 131.6MQ1 2025: 130.7MQ2 2025: 129.3MQ3 2025: 126.6MQ4 2025: 125.9MQ1 2026: 125.5MQ2 2026: 124.4MQ3 2026: 123.7MQ4 2026: 122.7MQ1 2027: 119.2MQ2 2024Q1 2027
Valuation36.5Q1 2027
16.533.049.666.1Q2 2024 · P/E: 22.0Q3 2024 · P/E: 26.0Q4 2024 · P/E: 22.2Q1 2025 · P/E: 20.8Q2 2025 · P/E: 66.1Q3 2025 · P/E: 20.4Q4 2025 · P/E: 16.7Q1 2026 · P/E: 29.2Q2 2026 · P/E: 21.6Q3 2026 · P/E: 21.3Q4 2026 · P/E: 15.7Q1 2027 · P/E: 36.5Q2 2024 · P/S: 0.8Q3 2024 · P/S: 0.8Q4 2024 · P/S: 0.9Q1 2025 · P/S: 1.0Q2 2025 · P/S: 0.7Q3 2025 · P/S: 0.8Q4 2025 · P/S: 0.9Q1 2026 · P/S: 0.9Q2 2026 · P/S: 0.9Q3 2026 · P/S: 1.0Q4 2026 · P/S: 1.1Q1 2027 · P/S: 0.9Q2 2024Q1 2027
P/EP/S
Revenue$403.4B2026
$100.9B$201.7B$302.6B$403.4B2019: $214.3B2020: $231.1B2021: $238.2B2022: $264B2023: $276.7B2024: $309B2025: $359.1B2026: $403.4B20192026
Net income$4.8B2026
-$2.2B$111.5M$2.4B$4.8B2019: $34M2020: $900M2021: -$4.5B2022: $1.1B2023: $3.6B2024: $3B2025: $3.3B2026: $4.8B20192026
EBITDA$7.2B2026
-$902.8M$1.8B$4.5B$7.2B2019: $1.8B2020: $2.3B2021: -$3.6B2022: $3.1B2023: $5.7B2024: $4.7B2025: $5.3B2026: $7.2B20192026
Free cash flow$5.4B2026
$1.4B$2.7B$4.1B$5.4B2019: $3.5B2020: $3.9B2021: $3.9B2022: $3.9B2023: $4.6B2024: $3.6B2025: $5.2B2026: $5.4B20192026
EPS$38.42026
-$10.7$5.68$22$38.42019: $0.172020: $4.952021: -$272022: $7.232023: $252024: $22.42025: $25.72026: $38.420192026
Cash / Debt$4B2026
$2.4B$4.7B$7.1B$9.4B2019 · Cash: $3B2019 · Debt: $7.6B2020 · Cash: $4B2020 · Debt: $9.4B2021 · Cash: $6.3B2021 · Debt: $9.4B2022 · Cash: $3.5B2022 · Debt: $7.5B2023 · Cash: $4.7B2023 · Debt: $7.3B2024 · Cash: $4.6B2024 · Debt: $7.4B2025 · Cash: $5.7B2025 · Debt: $7.4B2026 · Cash: $4B2026 · Debt: $8.6B20192026
CashDebt
Profitability+3.6%2026
-0.2%+1.6%+3.3%+5.0%2019 · Gross margin: +5.0%2020 · Gross margin: +4.9%2021 · Gross margin: +4.9%2022 · Gross margin: +4.8%2023 · Gross margin: +4.3%2024 · Gross margin: +3.9%2025 · Gross margin: +3.5%2026 · Gross margin: +3.6%2019 · Operating margin: +1.4%2020 · Operating margin: +1.3%2021 · Operating margin: +1.5%2022 · Operating margin: +1.0%2023 · Operating margin: +1.6%2024 · Operating margin: +1.3%2025 · Operating margin: +1.2%2026 · Operating margin: +1.6%2019 · Net margin: 0.0%2020 · Net margin: +0.4%2021 · Net margin: -1.9%2022 · Net margin: +0.4%2023 · Net margin: +1.3%2024 · Net margin: +1.0%2025 · Net margin: +0.9%2026 · Net margin: +1.2%20192026
Gross marginOperating marginNet margin
Revenue growth+12.4%2026
+4.1%+8.1%+12.2%+16.2%2020: +7.8%2021: +3.1%2022: +10.8%2023: +4.8%2024: +11.7%2025: +16.2%2026: +12.4%20192026
Shares outstanding124.1M2026
49.3M98.7M148M197.3M2019: 197.3M2020: 182M2021: 160.6M2022: 154.1M2023: 142.2M2024: 134.1M2025: 128.1M2026: 124.1M20192026
Valuation22.42026
169.4345.9522.5699.12019 · P/E: 699.12020 · P/E: 27.22021 · P/E: -7.22022 · P/E: 41.92023 · P/E: 14.12024 · P/E: 23.82025 · P/E: 26.02026 · P/E: 22.42019 · P/S: 0.12020 · P/S: 0.12021 · P/S: 0.12022 · P/S: 0.22023 · P/S: 0.22024 · P/S: 0.22025 · P/S: 0.22026 · P/S: 0.320192026
P/EP/S

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 202744.63$431.9B+7%9
FY 202850.55$462.2B+15%9
FY 202957.77$496.6B+23%3
FY 203067.67$515.5B+28%1
FY 203180.34$560.3B+39%1
Q2 202813.59$119.8B+16%4

Company events

6
2026-11-04EarningsActual - / Estimate 10.72-
2026-09-01Dividend$0.94-
2026-08-05EarningsActual 9.93 / Estimate 9.56Beat
2026-06-01Dividend$0.82-
2026-05-07EarningsActual 11.69 / Estimate 11.56Beat
2026-03-02Dividend$0.82-

Peer comparison

Similar listed perps
NameMarket capP/SP/EProfit marginVenues
REGN$80.8B5.218.7+27.9%6VRTX$129B10.229.3+34.9%3ISRG$139B12.644.4+28.4%8BSX$64.4B3.117.5+17.5%2MRNA$61.1B27.4-19.3-141.4%21PFE$157.3B2.536.5+6.8%3BIIB$31.8B3.237.9+8.4%3GILD$186.4B6.1-57.7-10.6%7

Analyst track record

How the analysts covering MCK have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings104285
Analysts1823
Buy / hold / sell87 / 17 / 0237 / 48 / 0
Upgrades / downgrades / initiations0 / 0 / 41 / 2 / 8
Price targets hit / missed19 / 73 (21%)189 / 73 (72%)
Avg. return after a rating (TipRanks)-6.4%+23.5%
Best / worst call+14.2% / -20.5%+95.5% / -20.5%

After buy calls on this stock: median 21-day move +2.7% vs S&P 500 +0.6% (n = 229)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Michael ChernyLeerink Partners100% hit rate on this stock · 16 targets measuredBuyno targetOct 6, 2025
  2. Eric ColdwellRobert W. Baird100% hit rate on this stock · 14 targets measuredBuytarget $1,015Aug 6, 2026
  3. Charles RhyeeTD Cowen100% hit rate on this stock · 14 targets measuredBuytarget $1,006Aug 6, 2026

Latest ratings

DateAnalystCallTarget
Sep 18, 2026Erin WrightMorgan StanleyBuyReiterated$977article ↗
Sep 15, 2026Elizabeth Anderson CFAEvercore ISIBuyMaintained$1,000article ↗
Sep 15, 2026Allen LutzBank of America SecuritiesBuyMaintained$1,050article ↗
Sep 16, 2026Allen LutzBank of America SecuritiesBuyReiterated$1,050article ↗
Sep 14, 2026Ryan HalstedRBC CapitalHoldMaintained$845article ↗
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$750$800$850$900$950$1,000Oct 25 · Buy 14 · Hold 2 · Sell 0Oct 25Nov 25 · Buy 14 · Hold 2 · Sell 0Dec 25 · Buy 15 · Hold 2 · Sell 0Dec 25Jan 26 · Buy 14 · Hold 2 · Sell 0Feb 26 · Buy 13 · Hold 2 · Sell 0Feb 26Mar 26 · Buy 12 · Hold 2 · Sell 0Apr 26 · Buy 10 · Hold 2 · Sell 0Apr 26May 26 · Buy 11 · Hold 2 · Sell 0Jun 26 · Buy 11 · Hold 2 · Sell 0Jun 26Jul 26 · Buy 11 · Hold 2 · Sell 0Aug 26 · Buy 12 · Hold 3 · Sell 0Aug 26Sep 26 · Buy 12 · Hold 3 · Sell 0Oct 25 · avg. target $840Nov 25 · avg. target $909Dec 25 · avg. target $916Jan 26 · avg. target $931Feb 26 · avg. target $972Mar 26 · avg. target $982Apr 26 · avg. target $965May 26 · avg. target $942Jun 26 · avg. target $931Jul 26 · avg. target $937Aug 26 · avg. target $979Sep 26 · avg. target $979Oct 25 · month-end close $811Nov 25 · month-end close $881Dec 25 · month-end close $820Jan 26 · month-end close $831Feb 26 · month-end close $987Mar 26 · month-end close $865Apr 26 · month-end close $815May 26 · month-end close $742Jun 26 · month-end close $756Jul 26 · month-end close $856Aug 26 · month-end close $885Sep 26 · month-end close $880

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data via FMP · computed Sep 18, 2026 · 104 ratings